Sergio Lupo

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 371 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Week 48 +14

A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)

Daniel Podzamczer, Elena Ferrer, Ezequiel Consiglio et al. · Antiviral Therapy · 2002 · 137 citations

Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial

Anton Pozniak, Javier O Morales-Ramirez, Elly Katabira et al. · AIDS · 2009 · 116 citations

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

John H. Beigel, Yajing Bao, Joy Beeler et al. · The Lancet Infectious Diseases · 2017 · 94 citations · Full text

Antiviral Drug Development, Antiviral Therapy, Virology +5

A comparison of time to exhaustion at [vdot]O2;max in elite cyclists, kayak paddlers, swimmers and runners

Véronique Billat, Marcello Faina, F Sardella et al. · Ergonomics · 1996 · 85 citations

Physical Activity, High-intensity Interval Training, Education +18